title: Androgenetic alopecia: combining medical and surgical treatments.
abstract: BACKGROUND
  Medical treatment or surgical reconstruction is used separately to treat androgenetic alopecia. Two drug molecules (5% minoxidil solution and oral finasteride 1 mg) have proven efficacy to stabilize hair loss and promote hair regrowth. Microtransplant of one to three hair follicular unit grafts can provide a definitive hair restoration with a natural appearance.
  
  
  OBJECTIVE
  Aesthetic results can be optimized with a combination of drugs and transplantation of follicular unit grafts. The Dynamic Multifactorial Classification is used to select suitable candidates for this combined approach and also to assess follow-up results.
  
  
  RESULTS
  Dynamic Multifactorial Classification assists the evaluation of the natural history of androgenetic alopecia evolution and also the effects of treatment. Regression of male androgenetic alopecia from Hamilton type V to type III can be achieved by combining drugs with hair grafts.
  
  
  CONCLUSIONS
  Improvement of investigative methods and especially the Dynamic Multifactorial Classification makes it easier for a patient to follow the results of treatment adapted to their case.
authors.affiliation: Center Sabouraud, Hôpital St. Louis, 14 rue Théodore de Banville, 75017 Paris, France. info@bouhanna.com
authors.forename: Pierre
authors.initials: P
authors.lastname: Bouhanna
mesh_terms: D000505:Alopecia / Q000188:drug therapy* / Q000601:surgery*; D003131:Combined Modality Therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D018120:Finasteride / Q000627:therapeutic use*; D018859:Hair Follicle / Q000637:transplantation*; D006801:Humans; D008297:Male; D008914:Minoxidil / Q000627:therapeutic use*; D016038:Skin Transplantation / Q000379:methods*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D004791:Enzyme Inhibitors; D014665:Vasodilator Agents; D018120:Finasteride; D008914:Minoxidil